AI assistant
INVION LIMITED — Director's Dealing 2019
Dec 22, 2019
65148_rns_2019-12-22_44df473f-cd81-4de5-b8bf-d4f4f03083bd.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Z Final Director’s Interest Notice
Rule 3.19A.3
Appendix 3Z
Final Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/9/2001.
| Name of entity | Invion Limited |
|---|---|
| ABN | 76 094 730 417 |
We (the entity) give ASX the following information under listing rule 3.19A.3 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of director | James Campbell |
|---|---|
| Date of last notice | 18 February 2019 |
| Date that director ceased to be director | 18 February 2019 |
Part 1 – Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
Number & class of securities
N/A
- See chapter 19 for defined terms.
Appendix 3Z Page 1
11/3/2002
Appendix 3Z Final Director’s Interest Notice
Part 2 – Director’s relevant interests in securities of which the director is not the registered holder
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Name of holder & nature of interest Number & class of securities Note: Provide details of the circumstances giving rise to the relevant interest Indirect holdings are Fusion 4,186,772 shares directly and indirectly held. Biosciences Pty Ltd of which Dr Campbell is a director; and James 20,443,211 Share options exercisable at $0.03 A Campbell and Kelly F Windmill each on or before 12 February 2023 (IVXAT). of which Dr Campbell is a beneficiary.
Part 3 – Director’s interests in contracts
==> picture [406 x 158] intentionally omitted <==
----- Start of picture text -----
Detail of contract N/A
Nature of interest
Name of registered holder
(if issued securities)
No. and class of securities to which
interest relates
----- End of picture text -----
- See chapter 19 for defined terms.
Appendix 3Z Page 2
11/3/2002